Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

1,306

Participants

Timeline

Start Date

April 18, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Prostate CancerDiagnosis
Interventions
PROCEDURE

Software fusion prostate biopsy

Software fusion biopsy: Each participant in this study arm will first undergo biopsy of the MRI-detected lesion using an image fusion platform such as UroNav or similar. Three biopsy cores will be taken per lesion, with a maximum of three lesions being sampled per participant. Then systematic samples will be taken from the remainder of the prostate as per standard protocol (10-12 cores).

PROCEDURE

Cognitive fusion prostate biopsy

Cognitive fusion biopsy: Each participant in this study arm will first undergo biopsy of the MRI-detected lesion using visual estimation and/or measurements of lesion. Three biopsy cores will be taken per lesion, with a maximum of three lesions being sampled per participant. Then systematic samples will be taken from the remainder of the prostate as per standard protocol (10-12 cores).

Trial Locations (4)

12208

RECRUITING

Albany Medical Center, Albany

17023

NOT_YET_RECRUITING

Pennsylvania State University, Hershey

01805

RECRUITING

Lahey Clinic, Inc, Burlington

R3A 1M5

NOT_YET_RECRUITING

Manitoba Prostate Centre, CancerCare Manitoba, Winnipeg

Sponsors
All Listed Sponsors
lead

Albany Medical College

OTHER